References
- Horning SJ. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993;20(Suppl. 5):75–88.
- Conconi A, Motta M, Bertoni F, et al Patterns of survival of follicular lymphomas at a single institution through three decades. Leuk Lymphoma 2010;51:995–1006.
- Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005;23:5019–5026.
- Campbell JK, Matthews JP, Seymour JF, Wolf MM, Juneja SK. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003;14:273–276.
- Johnson PW, Rohatiner AZ, Whelan JS, et al Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995;13:140–147.
- Dana BW, Dahlberg S, Nathwani BN, et al Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 1993;11:644–651.
- Al-Tourah AJ, Gill KK, Chhanabhai M, et al Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol 2008;26:5165–5169.
- Montoto S, Davies AJ, Matthews J, et al Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007 25:2426–2433.
- Tan D, Rosenberg SA, Levy R, et al Survival in follicular lymphoma: the Stanford experience, 1960–2003. Blood 2007;110(Suppl. 1): (Abstract 3428), pp. 1175.
- Liu Q, Fayad L, Cabanillas F, et al Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center. J Clin Oncol 2006;24:1582–1589.
- Sacchi S, Pozzi S, Marcheselli L, et al Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients. Cancer 2007;109:2077–2082.
- Schulz H, Bohlius JF, Trelle S, et al Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst 2007;99:706–714.
- Vidal L, Gafter-Gvili A, Leibovici L, Shpilberg O. Rituximab as maintenance therapy for patients with follicular lymphoma. Cochrane Database Syst Rev 2009;(2): CD006552.
- van Oers MH, Van Glabbeke M, Giurgea L, et al Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. J Clin Oncol 2010 May 3. [Epub ahead of print]
- Sebban C, Brice P, Delarue R, et al Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. J Clin Oncol 2008;26:3614–3620.